Theriva Biologics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $10.2M | $18.8M | $17.1M |
| FY2018 | $3.7M | $30.1M | $28.9M |
| FY2019 | $5.7M | $17.2M | $26.0M |
| FY2020 | $3.2M | $8.4M | $6.2M |
| FY2021 | $5.0M | $70.4M | $67.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $10.2M | $18.8M | $17.1M |
| FY2018 | $3.7M | $30.1M | $28.9M |
| FY2019 | $5.7M | $17.2M | $26.0M |
| FY2020 | $3.2M | $8.4M | $6.2M |
| FY2021 | $5.0M | $70.4M | $67.3M |